BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38352118)

  • 1. Formylated Peptide Receptor-1-Mediated Gut Inflammation as a Therapeutic Target in Inflammatory Bowel Disease.
    McAllister MJ; Hall R; Whelan RJ; Fischer LJ; Chuah CS; Cartlidge PD; Drury B; Rutherford DG; Duffin RM; Cartwright JA; Dorward DA; Rossi AG; Ho GT
    Crohns Colitis 360; 2024 Jan; 6(1):otae003. PubMed ID: 38352118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial DNA Is a Pro-Inflammatory Damage-Associated Molecular Pattern Released During Active IBD.
    Boyapati RK; Dorward DA; Tamborska A; Kalla R; Ventham NT; Doherty MK; Whitfield PD; Gray M; Loane J; Rossi AG; Satsangi J; Ho GT
    Inflamm Bowel Dis; 2018 Sep; 24(10):2113-2122. PubMed ID: 29718255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel role for endogenous mitochondrial formylated peptide-driven formyl peptide receptor 1 signalling in acute respiratory distress syndrome.
    Dorward DA; Lucas CD; Doherty MK; Chapman GB; Scholefield EJ; Conway Morris A; Felton JM; Kipari T; Humphries DC; Robb CT; Simpson AJ; Whitfield PD; Haslett C; Dhaliwal K; Rossi AG
    Thorax; 2017 Oct; 72(10):928-936. PubMed ID: 28469031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil infiltration of the colon is independent of the FPR1 yet FPR1 deficient mice show differential susceptibilities to acute versus chronic induced colitis.
    Farooq SM; Stadnyk AW
    Dig Dis Sci; 2012 Jul; 57(7):1802-12. PubMed ID: 22383080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis.
    Duvvuri B; Baddour AA; Deane KD; Feser ML; Nelson JL; Demoruelle MK; Lood C
    J Autoimmun; 2021 May; 119():102630. PubMed ID: 33713887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease.
    Li G; Lin J; Zhang C; Gao H; Lu H; Gao X; Zhu R; Li Z; Li M; Liu Z
    Gut Microbes; 2021; 13(1):1968257. PubMed ID: 34494943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESRRA (estrogen related receptor alpha) is a critical regulator of intestinal homeostasis through activation of autophagic flux via gut microbiota.
    Kim S; Lee JY; Shin SG; Kim JK; Silwal P; Kim YJ; Shin NR; Kim PS; Won M; Lee SH; Kim SY; Sasai M; Yamamoto M; Kim JM; Bae JW; Jo EK
    Autophagy; 2021 Oct; 17(10):2856-2875. PubMed ID: 33172329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wip 1 inhibits intestinal inflammation in inflammatory bowel disease.
    Zhang Q; Zhang C; Chang F; Liang K; Yin X; Li X; Zhao K; Niu Q; Tian Z
    Cell Immunol; 2016 Dec; 310():63-70. PubMed ID: 27687530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating intestinal inflammation in DSS-induced model of IBD.
    Kim JJ; Shajib MS; Manocha MM; Khan WI
    J Vis Exp; 2012 Feb; (60):. PubMed ID: 22331082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic Analysis Identifies Three Reliable Biomarkers of Intestinal Inflammation in the Stools of Patients With Inflammatory Bowel Disease.
    Vitali R; Palone F; Armuzzi A; Fulci V; Negroni A; Carissimi C; Cucchiara S; Stronati L
    J Crohns Colitis; 2023 Jan; 17(1):92-102. PubMed ID: 36040453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
    Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CARD9 in neutrophils protects from colitis and controls mitochondrial metabolism and cell survival.
    Danne C; Michaudel C; Skerniskyte J; Planchais J; Magniez A; Agus A; Michel ML; Lamas B; Da Costa G; Spatz M; Oeuvray C; Galbert C; Poirier M; Wang Y; Lapière A; Rolhion N; Ledent T; Pionneau C; Chardonnet S; Bellvert F; Cahoreau E; Rocher A; Arguello RR; Peyssonnaux C; Louis S; Richard ML; Langella P; El-Benna J; Marteyn B; Sokol H
    Gut; 2023 Jun; 72(6):1081-1092. PubMed ID: 36167663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AZ2158 is a more potent formyl peptide receptor 1 inhibitor than the commonly used peptide antagonists in abolishing neutrophil chemotaxis.
    Forsman H; Wu Y; Mårtensson J; Björkman L; Granberg KL; Dahlgren C; Sundqvist M
    Biochem Pharmacol; 2023 May; 211():115529. PubMed ID: 37004778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease.
    Foell D; Kucharzik T; Kraft M; Vogl T; Sorg C; Domschke W; Roth J
    Gut; 2003 Jun; 52(6):847-53. PubMed ID: 12740341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease.
    Zhou G; Yu L; Yang W; Wu W; Fang L; Liu Z
    Mediators Inflamm; 2016; 2016():2543070. PubMed ID: 27721573
    [No Abstract]   [Full Text] [Related]  

  • 19. PPARGC1A affects inflammatory responses in photodynamic therapy (PDT)-treated inflammatory bowel disease (IBD).
    Liu C; Jiang Y; Liu G; Guo Z; Jin Q; Long D; Zhou W; Qian K; Zhao H; Liu K
    Biochem Pharmacol; 2022 Aug; 202():115119. PubMed ID: 35667414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn's Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization.
    Ye C; Zhu S; Yuan J; Yuan X
    J Inflamm Res; 2024; 17():3949-3966. PubMed ID: 38911989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.